Showing results (31-40 of 216) with videos related to
Sort By:
Pageof 22
Biopreservation and Biobanking|December 16, 2014
Access to biobanks: harmonization across biobank initiativesMichiel Verlinden, Herman Nys, Nadine Ectors, et al.Journal of Market Access & Health Policy|July 29, 2024
Opportunities and Challenges in Cross-Country Collaboration: Insights from the Beneluxa InitiativeZilke Claessens, Michiel Lammens, Liese Barbier, et al.BMC Health Services Research|September 27, 2014
Drug shortages in European countries: a trade-off between market attractiveness and cost containment?Kim Pauwels, Isabelle Huys, Minne Casteels, et al.Trends in Cancer|August 8, 2017
Repurposing Drugs in Oncology: Next StepsCiska Verbaanderd, Lydie Meheus, Isabelle Huys, et al.BMC Medical Ethics|March 2, 2016
Qualitative study on custodianship of human biological material and data stored in biobanksMichiel Verlinden, Herman Nys, Nadine Ectors, et al.Frontiers in Pharmacology|May 10, 2021
Methodological Quality Assessment of Budget Impact Analyses for Orphan Drugs: A Systematic ReviewKhadidja Abdallah, Isabelle Huys, Kathleen Claes, et al.Frontiers in Pharmacology|May 31, 2021
How to Value Orphan Drugs? A Review of European Value Assessment FrameworksAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.Frontiers in Medicine|November 10, 2025
Early access disparities in innovative therapies across the US, EU, China, and JapanSanae Akodad, Michel Goldman, Hilde StevensBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 4, 2019
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!Binita Dutta, Isabelle Huys, Arnold G Vulto, et al.Frontiers in Pharmacology|September 8, 2017
Time Investment in Drug Supply Problems by Flemish Community PharmaciesElfi De Weerdt, Steven Simoens, Minne Casteels, et al.Pageof 22